Advocacy intelligence hub — real-time data for patient organizations
Programme National de Lutte contre l'Onchocercose, Republic of the Congo — PHASE3
Programme National de Lutte contre l'Onchocercose, Republic of the Congo — PHASE2, PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
François MISSAMOU, MD
Programme National de Lutte contre l'Onchocercose (PNLO)
Joseph KAMGNO
ISM (Higher Institute for Scientific and Medical Research)
Jéremy CAMPILLO, PharmD PhD
Institut de Recherche pour le Développement (IRD)
Amy D Klion, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
📍 BETHESDA, MD
Philippe LEISSNER
Bioaster